Key result
Exogenous palmitoyl-carnitine accumulates in cardiomyocytes exceeding metabolism, triggering cytotoxicity above 30 µM.
Answers are grounded in this paper and cite their sources.
Exogenous palmitoyl-carnitine is taken up by heart cells to a much greater extent than it is metabolized, suggesting an alternative form of fatty acid uptake that may contribute to toxicity in heart failure.
Background: The heart primarily uses long-chain fatty acids (FA), specifically palmitate (P), to fuel ATP synthesis. FA taken-up by transporters (e.g. CD36 and FATP3) are first attached to carnitine by CPT1 to form acyl-carnitines (AC), such as palmitoyl-carnitine (PC), that can then be imported into mitochondria. FA metabolism is reduced in heart failure (HF) with ACs found lower in myocardium but increased in plasma. In normal human plasma PC is ~1uM while P is 400mM. Whether cardiomyocytes (CMs) can take up PC and oxidize it for use in the TCA remains unknown. Research Question/Aim: To test whether exogenous PCs can be (a) taken up and (b) oxidized by CMs independent of CPT1. Methods: Neonatal rat cardiomyocytes (NRVMs), cardiac fibroblasts (NRVFs), adult mouse cardiomyocytes (AMs), and human endothelial coronary artery cells (HECAs) were cultured with 5uM C 14 PC or C 14 P and oxidation assayed by radioactive CO 2 release. Results: C 14 PC is taken up by AM (5% PC vs 21% of C 14 Palmitate), NRVMs (35% vs 65%), NRVFs (6% vs 30%), HECA (9% vs 23%), as well as various other organ derived cells. The uptake of PC vs P is distinct and not competitive within each cell type. AM and NRVM metabolize PC at <5%. NRVM metabolism of PC can be increased from 1.5 to 2.5% by high lipid treatment prior to C 14 PC exposure. The increase is lost by CPT1 inhibition (via 20uM etomoxir), indicating exogenous PC metabolism in heart cells occurs via intracellular division to carnitine and P. In cardiomyocytes, we found extracellular PC concentration above 30µM resulted in cytotoxicity. We show CD36, FATP3, and CPT1b protein levels are reduced in human failing myocardium. Conclusion: Exogenous PC is taken up by heart cells to a much greater extent than metabolized. As protein expression of key FA transporters is decreased, we propose an alternative form of FA uptake through an AC specific plasma membrane transporter and a cytoplasmic mechanism for division to mitigate toxicity. Whether cardiac cells in HF are similarly able to take up or metabolize PC and if this contributes to toxicity in HF is unknown.
No takes yet. Share an insight, caveat, or question.
Mulligan et al. (2025) studied Heart failure. Exogenous palmitoyl-carnitine (C14 PC) vs. C14 Palmitate (C14 P) was evaluated on Cellular uptake and oxidation of C14 PC. Exogenous palmitoyl-carnitine is taken up by heart cells to a much greater extent than it is metabolized, with extracellular concentrations above 30µM resulting in cytotoxicity.
Synapse has enriched 10 related papers. Consider them for comparative context: